5-[1-(3,5-Dimethylphenyl)prop-1-en-2-yl]-1H-tetrazole

ID: ALA4555949

PubChem CID: 141701410

Max Phase: Preclinical

Molecular Formula: C12H14N4

Molecular Weight: 214.27

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(=Cc1cc(C)cc(C)c1)c1nnn[nH]1

Standard InChI:  InChI=1S/C12H14N4/c1-8-4-9(2)6-11(5-8)7-10(3)12-13-15-16-14-12/h4-7H,1-3H3,(H,13,14,15,16)

Standard InChI Key:  MSBXQLLNIIDBLQ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 16 17  0  0  0  0  0  0  0  0999 V2000
    6.6419   -8.1252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6419   -8.9494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3571   -9.3615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3571  -10.1858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0682  -10.5979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6419  -10.5979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9268  -10.1858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2158  -10.5979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5006  -10.1858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7854  -10.5979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5006   -9.3615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8316   -8.8773    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0885   -8.0933    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9127   -8.0933    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1696   -8.8773    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9268   -9.3615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  3
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 11 15  1  0
  7 16  2  0
  2 16  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4555949

    ---

Associated Targets(Human)

GABRA1 Tclin GABA-A receptor; alpha-1/beta-3/gamma-2 (1565 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 214.27Molecular Weight (Monoisotopic): 214.1218AlogP: 2.38#Rotatable Bonds: 2
Polar Surface Area: 54.46Molecular Species: ACIDHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 4.32CX Basic pKa: CX LogP: 3.27CX LogD: 1.67
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.83Np Likeness Score: -1.01

References

1. Stadler M, Monticelli S, Seidel T, Luger D, Salzer I, Boehm S, Holzer W, Schwarzer C, Urban E, Khom S, Langer T, Pace V, Hering S..  (2018)  Design, Synthesis, and Pharmacological Evaluation of Novel β2/3 Subunit-Selective γ-Aminobutyric Acid Type A (GABAA) Receptor Modulators.,  62  (1): [PMID:30289721] [10.1021/acs.jmedchem.8b00859]

Source